We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 51.53%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 9.95%
4 Consumer Discretionary 8.03%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQPT
2076
EquipmentShare.com Inc
EQPT
$4.4B
$1.11M ﹤0.01%
56,672
-359,967
-86% -$7.71M
CPRT icon
2077
Copart
CPRT
$25.5B
$1.1M ﹤0.01%
39,142
+25,620
+189% +$827K
VTS icon
2078
Vitesse Energy
VTS
$705M
$1.1M ﹤0.01%
69,961
+36,439
+109% +$645K
EOG icon
2079
PUT
EOG Resources
EOG
$73.6B
$1.1M ﹤0.01%
8,500
-19,700
-70% -$2.68M
ORKA
2080
Oruka Therapeutics
ORKA
$5.59B
$1.1M ﹤0.01%
+11,586
New +$772K
EQ icon
2081
Equillium
EQ
$106M
$1.1M ﹤0.01%
344,409
-1,294,361
-79% -$3.1M
PRAA icon
2082
PRA Group
PRAA
$777M
$1.1M ﹤0.01%
+58,005
New +$1.03M
WMK icon
2083
Weis Markets
WMK
$1.78B
$1.1M ﹤0.01%
14,061
-16,372
-54% -$1.2M
PLUG icon
2084
PUT
Plug Power
PLUG
$2.77B
$1.1M ﹤0.01%
406,000
– –
APPN icon
2085
Appian
APPN
$2.58B
$1.09M ﹤0.01%
+47,684
New +$1.06M
RVMD icon
2086
PUT
Revolution Medicines
RVMD
$43.9B
$1.09M ﹤0.01%
5,800
-44,200
-88% -$6.46M
NSLR
2087
Neostellar Capital Corp
NSLR
$211M
$1.09M ﹤0.01%
+86,594
New +$1.14M
EXC icon
2088
Exelon
EXC
$41.6B
$1.08M ﹤0.01%
23,268
+3,932
+20% +$182K
MLM icon
2089
Martin Marietta Materials
MLM
$34.4B
$1.08M ﹤0.01%
1,878
+978
+109% +$580K
NTRS icon
2090
Northern Trust
NTRS
$32.2B
$1.08M ﹤0.01%
6,224
+1,980
+47% +$326K
CARE icon
2091
Carter Bankshares
CARE
$702M
$1.08M ﹤0.01%
31,801
+20,980
+194% +$568K
SGRY icon
2092
Surgery Partners
SGRY
$1.89B
$1.08M ﹤0.01%
+64,377
New +$904K
FCT
2093
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
$1.08M ﹤0.01%
111,522
-100
-0.1% -$967
KRSA
2094
Korsana Biosciences, Inc. Common Stock
KRSA
$1.41B
$1.08M ﹤0.01%
+45,359
New +$1.03M
SPSC icon
2095
SPS Commerce
SPSC
$2.93B
$1.07M ﹤0.01%
18,717
-71,881
-79% -$3.97M
CMI icon
2096
CALL
Cummins
CMI
$72.3B
$1.07M ﹤0.01%
+1,500
New +$988K
RL icon
2097
Ralph Lauren
RL
$21.3B
$1.07M ﹤0.01%
2,664
-98,915
-97% -$36.8M
SYF icon
2098
PUT
Synchrony
SYF
$23.7B
$1.06M ﹤0.01%
14,000
+5,200
+59% +$382K
CRVL icon
2099
CorVel
CRVL
$3.75B
$1.06M ﹤0.01%
16,990
-13,222
-44% -$771K
BNY
2100
Bank of New York Mellon
BNY
$102B
$1.06M ﹤0.01%
+7,340
New +$1M

Similar funds

Balyasny Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Balyasny Asset Management held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Balyasny Asset Management withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Balyasny Asset Management opened a new position in SpaceX worth $581M.

  • Balyasny Asset Management's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Balyasny Asset Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Balyasny Asset Management fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Balyasny Asset Management's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Balyasny Asset Management opened 834 new positions and closed 734 in Q2 2026.
  • Balyasny Asset Management's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.